Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach-Reference-Cited by-同舟云学术

Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach

Published:2017-12-06 Issue:4 Volume:20 Page:553-561
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Fang Enhao,Zhang Xiuqing,Wang Qi,Wang Daoming

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference46 articles.

1. Trends in prostate cancer in the United States;Brawley;J Natl Cancer Inst Monogr,2012

2. Human prostate cancer risk factors;Bostwick;Cancer,2004

3. SocietyAC., What are the Key Statistics about Prostate Cancer, http://www.cancer.org/cancer/prostatecancer/detailedguide/ prostate-cancer-key-statistics(accessed June 2015).

4. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

5. The present and future of biomarkers in prostate cancer: Proteomics, genomics, and immunology advancements;Gaudreau;Biomark Cancer,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of prostate cancer associated genes for diagnosis and prognosis: a modernized in silico approach;Mammalian Genome;2024-08-17

2. Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer;International Journal of Molecular Sciences;2023-02-06

3. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas;Cancer Biomarkers;2023-01-20

4. Bioinformatics approach to identify the core ontologies, pathways, signature genes and drug molecules of prostate cancer;Informatics in Medicine Unlocked;2023

5. Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis;Toxicology and Applied Pharmacology;2022-10